Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study.

about

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study.

Item

http://www.wikidata.org/entity/Q52576558

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Efficacy of bendamustine and r ...... , ERIC and UK CLL FORUM study.

@en

Efficacy of bendamustine and r ...... , ERIC and UK CLL FORUM study.

@nl

type

Item

label

Efficacy of bendamustine and r ...... , ERIC and UK CLL FORUM study.

@en

Efficacy of bendamustine and r ...... , ERIC and UK CLL FORUM study.

@nl

prefLabel

Efficacy of bendamustine and r ...... , ERIC and UK CLL FORUM study.

@en

Efficacy of bendamustine and r ...... , ERIC and UK CLL FORUM study.

@nl

P1476

Efficacy of bendamustine and r ...... A, ERIC and UK CLL FORUM study

@en

P2093

Agostino Cortelezzi

http://www.w3.org/2001/XMLSchema#string

Alessandra Tedeschi

http://www.w3.org/2001/XMLSchema#string

Alfonso Piciocchi

http://www.w3.org/2001/XMLSchema#string

Alfredo Rivas Delgado

http://www.w3.org/2001/XMLSchema#string

Angela Amendola

http://www.w3.org/2001/XMLSchema#string

Angeles Medina Perez

http://www.w3.org/2001/XMLSchema#string

Anna Schuh

http://www.w3.org/2001/XMLSchema#string

Antonio Cuneo

http://www.w3.org/2001/XMLSchema#string

Atto Billio

http://www.w3.org/2001/XMLSchema#string

Ben Kennedy

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia

Routine treatment of patients with chronic lymphocytic leukaemia by office-based haematologists in Germany-data from the Prospective Tumour Registry Lymphatic Neoplasms.

An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.

Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group.

Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group.

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.

Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial.

Ibrutinib for relapsed/refractory chronic lymphocytic leukemia: a UK and Ireland analysis of outcomes in 315 patients

P304

1209-1217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2018.189837

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29674504

http://www.w3.org/2001/XMLSchema#string

P932

6029555

http://www.w3.org/2001/XMLSchema#string